 |
Adeno-associated viral-based vector cystic fibrosis gene therapy |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1995-02-15 00:00:00 |
| Sponsor | Targeted Genetics Corporation;1100 Olive Way, Suite 100;Seattle, Washington, 98101 |
Related Access Program